Cafepharma Today

May 28 2025 - GLP-1 prescriptions for weight loss soar, despite obstacles
GLP-1 prescriptions for weight loss soar, despite obstacles
FDA approves use of Sanofi's meningococcal vaccine in infants
GSK's $66M bet on Spero's rejected UTI antibiotic pays off with a phase 3 win
AbbVie's Allergan Aesthetics unit plots 202 layoffs after recent sales slide
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Rexahn: Holes Galore in Serdaxin Data
TheStreet.com
Monday, April 19, 2010 - 11:29am
tags:
Rexahn, Serdaxin, antidepressants
Elan Revives Plan to Spin Off Its Drug Delivery Unit
Bloomberg
Monday, April 19, 2010 - 11:14am
tags:
Elan, drug delivery
Old Line Treatment Bests Lilly Drug in Breast-Cancer Prevention
WSJ Online
Monday, April 19, 2010 - 11:11am
tags:
Eli Lilly, tamoxifen, breast cancer, Evista
Javelin Pharmaceuticals ends deal with Myriad
Yahoo/AP
Monday, April 19, 2010 - 11:10am
tags:
Javelin, Myriad, partnerships
Earnings Preview: J&J sales growth key to rebound
Yahoo/AP
Monday, April 19, 2010 - 11:09am
tags:
earnings, JNJ
Human Genome Sciences' partner Novartis pulls European application for hepatitis C drug
Yahoo/AP
Monday, April 19, 2010 - 11:08am
tags:
Human Genome Sciences, Novartis, Joulferon, Europe, hepatitis C
Those FDA Warning Letters To Glaxo & Novartis
Pharmalot
Monday, April 19, 2010 - 11:05am
tags:
FDA, warnings, GSK, Novartis, Arzerra, Vesicare, Astellas, Voltaren
The PhRMA Search for a New Leader
InVivo
Monday, April 19, 2010 - 11:02am
tags:
PhRMA
Astellas Won’t Raise OSI Bid on FDA Decision Alone
Bloomberg
Monday, April 19, 2010 - 11:01am
tags:
Astellas, FDA, OSI Pharmaceuticals, M&A
Onyx Drug Shows Broader Potential in Cancer Studies
Bloomberg
Monday, April 19, 2010 - 10:57am
tags:
ONYX Pharmaceuticals, cancer, Bayer, Nexavar
Novartis Races to Be First With Oral MS Drug
Seeking Alpha
Monday, April 19, 2010 - 10:57am
tags:
Novartis, multiple sclerosis, MS, Biogen Idec, Merck
Eli Lilly Earnings Fall 5%
TheStreet.com
Monday, April 19, 2010 - 10:55am
tags:
Eli Lilly, earnings
Two Healthcare Stocks I Like Best
Seeking Alpha
Monday, April 19, 2010 - 10:55am
tags:
Abbott Laboratories, Eli Lilly, Covidien
FDA Weighs Halting Avandia Safety Study
WSJ Online
Sunday, April 18, 2010 - 3:15pm
tags:
GSK, Avandia, diabetes
Abbott Must Hand Over CEO Emails: Biotech's Latest Trials and Tribulations
Seeking Alpha
Sunday, April 18, 2010 - 12:28pm
tags:
Abbott Laboratories, Depakote, off label
Alberta wants refund on H1N1 vaccine
Calgary Herald, Canada
Sunday, April 18, 2010 - 12:27pm
tags:
H1N1 vaccines, GSK
Paxil Off-Label Use to Be Focus of Heart Defects Trial
Lawyers and Settlements
Sunday, April 18, 2010 - 12:24pm
tags:
Paxil, off label, lawsuits
Watson's Generic Toprol XL(R) 100 mg and 200 mg Receives FDA Approval
PR-USA
Sunday, April 18, 2010 - 12:22pm
tags:
Watson Pharmaceuticals, Toprol XL
Circadian's VGX-100 Significantly Inhibits Tumour Growth In Animal Models Of Human Cancer
Medical News Today
Sunday, April 18, 2010 - 12:19pm
tags:
Circadian Technologies, VGX-100, VEGF-C growth factor, cancer, Docetaxel, Avastin
Akorn, Inc. Announces FDA Approval For Hydromorphone Hydrochloride Injection 10mg/ml In 1ml, 5ml And 50ml Doses
Medical News Today
Sunday, April 18, 2010 - 12:17pm
tags:
Akorn, Dilaudid, hydromorphone hydrochloride

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.